Ages Eligible for Study: up to 17
Genders Eligible for Study: Both
- Diagnosis of JIA (any subtype).
- Age < 18 years at the time of enrollment.
- Receiving Abatacept at the time of enrollment as per treating physician's decision.
- Parent or legally acceptable representative willing to participate in the study and sign the informed consent.